ResearcherKing's College LondonNo recent work listed
Claire M. Wells
Matched on ORCID iD 0000-0003-1926-6282; OpenAlex author ID A5021719937. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers
Papers 7
- Targeted Sequencing of Pancreatic Ductal Adenocarcinoma Tissue Last author DOI 10.1101/2023.01.13.523431↗
- CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Co-author DOI 10.1126/sciadv.adi0244↗
- Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. Co-author DOI 10.1016/j.biomaterials.2020.120369↗
- TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells. Last author DOI 10.1186/s12885-019-6429-z↗
- PAK4 pathway as a potential therapeutic target in pancreatic cancer. Last author DOI 10.2217/fon-2017-0458↗
- PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. Last author DOI 10.1038/srep42575↗
- Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? Last author DOI 10.18632/oncotarget.13309↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Debashis Sarker · 4 shared papers, 2017–2023 · strength 0.61
- Paper Targeted Sequencing of Pancreatic Ductal Adenocarcinoma Tissue DOI 10.1101/2023.01.13.523431↗
- Paper PAK4 pathway as a potential therapeutic target in pancreatic cancer. DOI 10.2217/fon-2017-0458↗
- Paper CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. DOI 10.1126/sciadv.adi0244↗
- Christian Benzing · 2 shared papers, 2019–2023 · strength 0.34
- Kiruthikah Thillai · 3 shared papers, 2017–2018 · strength 0.31
- Paper PAK4 pathway as a potential therapeutic target in pancreatic cancer. DOI 10.2217/fon-2017-0458↗
- Paper Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? DOI 10.18632/oncotarget.13309↗
- Paper PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. DOI 10.1038/srep42575↗
- Kiruthikah Thailli · 1 shared paper, 2023 · strength 0.24
- Hemant Mahendrakumar Kocher · 2 shared papers, 2017–2023 · strength 0.21
- Victoria Sanz‐Moreno · 1 shared paper, 2023 · strength 0.13
- Rémi Samain · 1 shared paper, 2023 · strength 0.13
- Juliana B. Candido · 1 shared paper, 2023 · strength 0.13
- Khuloud T. Al‐Jamal · 1 shared paper, 2021 · strength 0.12
- Lizhou Xu · 1 shared paper, 2021 · strength 0.12
- Prabhu Arumugam · 1 shared paper, 2017 · strength 0.08
- Helen A. King · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.